MALIBU, Calif., Oct. 28, 2019 /PRNewswire/ -- Progenabiome, a physician-owned genetic sequencing laboratory, found cutting-edge data on Clostridium difficile (C.diff), a disease burdening 500,000+ Americans yearly. They will present a validated, verified, and reproduced C.diff Assay at The American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting o

BOCA RATON, Fla., Oct. 28, 2019 /PRNewswire/ -- Celsius Holdings, Inc. (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today announced that it completed the previously announced financial restructuring and acquisition of Func Food Group Oyj ("Func Food") on October 25, 2019. Consideration for the transact

SALT LAKE CITY, Oct. 28, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate

SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Prometheus Biosciences, Inc., a biopharmaceutical company, announced today the appointments of Chris Slavinsky as general counsel and head of business development, and Mike Walther as chief commercial officer, to its executive management team. Prometheus

LAS VEGAS, Oct. 28, 2019 /PRNewswire/ -- Today at the HLTH conference, Crossover Health launched its Connected System of Health. The new offering enables self-insured employers to deliver comprehensive primary care services, alongside care management and coordination of secondary care, from a digital-first, national medical group. The focus of the Connected System o

MIAMI, Oct. 28, 2019 /PRNewswire/ -- HealthSnap, a leading digital and lifestyle health platform, and

SAN FRANCISCO and DUBLIN, Oct. 28, 2019 /PRNewswire/ -- Medicines360, a global nonprofit organization with a mission to expand women's access to quality medicines, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved Medicines360's Supplemental New Drug

COVINGTON, La., Oct. 28, 2019 /PRNewswire/ -- At Your Service, a new division of Christwood, the Northshore's premier retirement community, today announced the Innovations in Aging Extravaganza to officially launch a new endeavor to provide comprehensive in home wellness and home maintenance care for non-residents of Christwood who wish to stay at home and ag

CHICAGO, Oct. 28, 2019 /PRNewswire/ -- EVERSANA™, the leading independent provider of commercial services to the life science industry, has been certified as a

TOKYO, Oct. 28, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of ASP1128 for patients at increased risk of developing moderate to severe acute kidney injury (AK